Simplex Trading’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-25,000
| Closed | -$443K | – | 10215 |
|
|
2025
Q3 | $443K | Sell |
25,000
-27,300
| -52% | -$2.85M | ﹤0.01% | 3974 |
|
|
2025
Q2 | $4.95M | Buy |
52,300
+12,600
| +32% | +$933K | ﹤0.01% | 1355 |
|
|
2025
Q1 | $2.52M | Buy |
39,700
+8,400
| +27% | +$502K | ﹤0.01% | 1834 |
|
|
2024
Q4 | $1.45M | Sell |
31,300
-24,500
| -44% | -$920K | ﹤0.01% | 2499 |
|
|
2024
Q3 | $1.6M | Sell |
55,800
-26,200
| -32% | -$645K | ﹤0.01% | 2470 |
|
|
2024
Q2 | $1.19M | Buy |
82,000
+72,900
| +801% | +$1.06M | ﹤0.01% | 2748 |
|
|
2024
Q1 | $146K | Sell |
9,100
-2,200
| -19% | -$38K | ﹤0.01% | 5184 |
|
|
2023
Q4 | $224K | Buy |
11,300
+5,800
| +105% | +$85.6K | ﹤0.01% | 4562 |
|
|
2023
Q3 | $89K | Buy |
5,500
+2,100
| +62% | +$40.4K | ﹤0.01% | 5210 |
|
|
2023
Q2 | $71K | Sell |
3,400
-15,100
| -82% | -$322K | ﹤0.01% | 5475 |
|
|
2023
Q1 | $371K | Sell |
18,500
-76,700
| -81% | -$1.66M | ﹤0.01% | 3582 |
|
|
2022
Q4 | $2.49M | Buy |
95,200
+87,700
| +1,169% | +$1.17M | ﹤0.01% | 1701 |
|
|
2022
Q3 | $76K | Buy |
+7,500
| New | +$63.2K | ﹤0.01% | 5892 |
|
|
2022
Q1 | – | Sell |
-1,800
| Closed | -$12K | – | 11487 |
|
|
2021
Q4 | $12K | Buy |
1,800
+1,100
| +157% | +$5.62K | ﹤0.01% | 8887 |
|
|
2021
Q3 | $4K | Hold |
700
| – | – | ﹤0.01% | 9367 |
|
|
2021
Q2 | $4K | Buy |
+700
| New | +$4.85K | ﹤0.01% | 9548 |
|
Other funds holding VRNA
Simplex Trading's VRNA Position: Q4 2025 in Review
Simplex Trading sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 2,641 shares — an estimated $281K sold.
Simplex Trading first reported a position in VRNA in Q4 2021 and held it in 12 quarters. The position peaked at $1.86M in Q4 2022. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.
- Simplex Trading reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 2,641 Verona Pharma shares in Q4 2025, an estimated $281K.
- Simplex Trading first reported a position in Verona Pharma in Q4 2021 and held it in 12 quarters.
- Simplex Trading's Verona Pharma position peaked at $1.86M in Q4 2022.
- 1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.